Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vir Biotechnology, Inc.”

6 pharma patents match "Vir Biotechnology, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Vir Biotechnology, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Vir Biotechnology, Inc.” · 30,257 patents in full index Clear search

  1. US 12404318

    Combination HBV therapy

    Vir Biotechnology, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

    granted

  2. US 11628215

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted

  3. US 11554168

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Jan 17, 2023 · Expires Jan 12, 2043

    granted

  4. US 11479599

    Antibodies against SARS-CoV-2 and methods of using the same

    Vir Biotechnology, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted

  5. US 11168128

    Antibodies against SARS-CoV-2 and methods of using the same

    Vir Biotechnology, Inc. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  6. US 10894078

    HIV vaccines comprising one or more population episensus antigens

    Vir Biotechnology, Inc. · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.